According to the National Statistics Committee, Uzbekistan’s large enterprises produced basic pharmaceutical products and pharmaceutical preparations worth nearly UZS 3 trillion in January–May 2026.
This figure increased by 22.3% compared to the corresponding period of 2025.
Production by region:
Tashkent city — UZS 1.8 trillion;
Syrdarya region — UZS 443.6 billion;
Tashkent region — UZS 226.4 billion;
Namangan region — UZS 169.1 billion;
Samarkand region — UZS 116.9 billion;
Andijan region — UZS 71.4 billion;
Fergana region — UZS 53.4 billion;
Surkhandarya region — UZS 49.3 billion;
Kashkadarya region — UZS 15.4 billion;
Khorezm region — UZS 12.1 billion;
Bukhara region — UZS 7.8 billion;
Republic of Karakalpakstan — UZS 3.5 billion;
Jizzakh region — UZS 0.1 billion;
Navoi region — UZS 0.1 billion.



